EFADuo® (Omega-3 and Omega-6 Complex)

Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

EFADuo® supplies a balanced complex of essential fatty acids, including omega-3 EPA and DHA. The best-established benefit of EPA and DHA is lowering triglycerides. Broader claims for brain, skin, and inflammatory health are mechanistic and are not backed by trials cited here.

Studied Dose Commonly 1 to 3 g of combined EPA and DHA per day.
Active Compound Omega-3 fatty acids EPA and DHA, from fish, krill, or algae.

Benefits

Healthy triglycerides

Omega-3 fatty acids reliably lower triglycerides, one of the best-established benefits of EPA and DHA for heart health.

Brain and mood support

DHA is a major structural fat in the brain. Large omega-3 trials for cognition and mood exist but are mixed, and none are cited on this page, so treat this as a mechanistic rationale rather than a proven effect of this product.

Anti-inflammatory support

EPA and DHA are converted into signaling molecules involved in resolving inflammation. This is a mechanism; no human trial measuring an inflammatory outcome for this product is cited.

Mechanism of action

1

Membrane incorporation

EPA and DHA are built into cell membranes throughout the body, improving membrane function in the heart, brain, and eyes.

2

Eicosanoid balance

Omega-3s are converted into specialized signaling molecules (resolvins and prostaglandins) that help resolve inflammation.

Clinical trials

1
Omega-3 and Cardiovascular Health — Cochrane Review
PubMed

Cochrane systematic review of omega-3 fatty acids for prevention of cardiovascular disease. (Abdelhamid et al. 2020, Cochrane Database of Systematic Reviews)

Adults across many large trials.

Omega-3 supplementation reduced triglycerides; the review found only small effects on overall cardiovascular events, so expectations for heart-attack prevention should be modest.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Fishy aftertaste, burping, or mild digestive upset can occur.
Take with meals and choose a quality, oxidation-tested oil.

Important Drug interactions

Anticoagulants and antiplatelets — high-dose omega-3 may increase bleeding risk; monitor.
Blood pressure medication — possible mild additive effect.
Tell your doctor before surgery if taking high doses.

Frequently asked questions about EFADuo® (Omega-3 and Omega-6 Complex)

What is EFADuo?

EFADuo® supplies a balanced complex of essential fatty acids, including omega-3 EPA and DHA. The best-established benefit of EPA and DHA is lowering triglycerides. Broader claims for brain, skin, and inflammatory health are mechanistic and are not backed by trials cited here.

What is EFADuo used for?

EFADuo is researched primarily for Cardiovascular. Omega-3 fatty acids reliably lower triglycerides, one of the best-established benefits of EPA and DHA for heart health.

What is the recommended dosage of EFADuo?

The clinically studied dose is Commonly 1 to 3 g of combined EPA and DHA per day. Always follow the product label and check with a healthcare provider for personal advice.

Is EFADuo safe, and does it have side effects?

For most healthy adults, EFADuo is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Fishy aftertaste, burping, or mild digestive upset can occur. It may also interact with some medications. EFADuo is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does EFADuo interact with any medications?

Possible interactions include: Anticoagulants and antiplatelets — high-dose omega-3 may increase bleeding risk; monitor. Blood pressure medication — possible mild additive effect. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for EFADuo?

NutraSmarts rates the evidence for EFADuo as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177..PubMedUsed to support: In 86 randomized trials (162,796 adults), increasing long-chain omega-3 (EPA and DHA) reliably lowered triglycerides by about 15% in a dose-dependent way (high-certainty), but had little or no effect on all-cause mortality (RR 0.97) or cardiovascular events (RR 0.96), both high-certainty. This is generic omega-3 evidence, not a trial of this branded complex.